Hetero

Hetero Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest produc

Hetero is one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Having 20+ years of expertise in the pharmaceutical industry, Hetero’s strategic business areas include APIs, Formulations, Biosimilars and Custom Pharmaceutical Services (CPS). The company is recognized for its strengths in Research and Development, Manufacturing and Commercialization of a wide range of products around the world. Hetero has 25+ state-of-the-art manufacturing facilities strategically located worldwide. And a majority of these facilities have been approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC - South Africa among others. We are endowed with a robust portfolio of above 200 products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, etc. Hetero has a strong global presence in 120+ countries and focusses on making affordable medicines accessible to patients worldwide.

10/03/2026

At Hetero, our growth story is powered by people and the teams that enable them to thrive.

The meeting also provided a platform for cross-learning and discussions on how technology can further strengthen HR practices and effectiveness, reinforcing HR’s critical role in driving culture and talent strategy at Hetero.

In his inaugural address, our Managing Director Dr. Vamsi Krishna Bandi appreciated the contributions of various teams in strengthening our people ecosystem.

He emphasized leadership’s commitment to building psychological safety and improving the employee happiness index.

The meet also provided a platform for cross-learning and discussions on how technology can further strengthen HR practices and effectiveness, reinforcing HR’s critical role in driving culture and talent strategy at Hetero.

08/03/2026

Farmacy is Family. And every family stands stronger because of women.

This International Women’s Day, we honour the force women bring to life and progress. The caregivers and changemakers. The scientists and storytellers. The leaders, learners, builders, and believers who quietly and courageously move the world forward every single day.

At Hetero, we are proud to be part of a world shaped by their strength, empathy, and determination.

Happy International Women’s Day.

Obesity affects over a billion people globally and remains one of today’s most pressing health challenges.At Hetero, we ...
04/03/2026

Obesity affects over a billion people globally and remains one of today’s most pressing health challenges.

At Hetero, we believe addressing obesity begins with awareness, evidence-based understanding, and equitable access to healthcare.

This World Obesity Day, we reaffirm our commitment to improving health outcomes for communities across the world.

25/02/2026

Hetero is proud to participate in DCAT Week 2026 — the premier gathering of the global bio/pharmaceutical manufacturing community.

Meet our team at Suite #708, InterContinental Barclay, New York.
📅 March 23-26, 2026

Let’s connect and collaborate.

19/02/2026

Two inspiring days at BioAsia 2026 - Asia’s leading life sciences and healthcare forum - driving global partnerships and meaningful progress toward a healthier world.

At Hetero, we remain focused on advancing science, strengthening supply resilience, and delivering trusted pharmaceutical solutions at scale.

Thank you to our partners and industry peers for making these conversations truly impactful.

We’re excited to be part of BioAsia 2026.At Hetero, collaboration drives progress. From science to scalable manufacturin...
13/02/2026

We’re excited to be part of BioAsia 2026.

At Hetero, collaboration drives progress. From science to scalable manufacturing, we remain committed to delivering reliable pharmaceutical solutions that serve patients worldwide.

Meet our team at Booth S8 as we engage with partners across the global life sciences ecosystem.

📅 Feb 17–18, 2026 | HITEX, Hyderabad

Epilepsy is one of the most common neurological conditions globally.With timely diagnosis and appropriate treatment, up ...
09/02/2026

Epilepsy is one of the most common neurological conditions globally.

With timely diagnosis and appropriate treatment, up to 70% of people with epilepsy can live seizure-free. However, access to care remains uneven, highlighting the importance of awareness, early intervention, and sustained treatment.

At Hetero, advancing access to quality healthcare remains central to building better health outcomes.

04/02/2026

Cancer remains a major global public health challenge and a leading cause of death worldwide.
Yet up to half of all cancers are preventable through early screening and timely treatment.

At Hetero, we believe access to healthcare begins with awareness and action. We remain committed to advancing affordable medicines, early intervention, and timely care—so prevention and treatment reach those who need them most.

26/01/2026

Vande Mataram 🇮🇳
This Republic Day, we bow in respect to the land that nurtures us, the Constitution that gives us direction,
and the people whose resilience gives India its strength.
At Hetero, nation-building begins with responsibility: to serve India with integrity, equity, and care.

Wishing the country a proud 77th Republic Day.

14/01/2026

Harvest festivals celebrate nature's goodness, the joy of togetherness, and the promise of renewal and hope. While their names vary across regions, the spirit they embody is universal.

Makar Sankranti marks a season when the rhythms of harvest resonate across cultures and regions.

At Hetero, this shared spirit inspires us to transform science into affordable medicines - enhancing lives everywhere and helping build a brighter, healthier world for all.

Cervical cancer is largely preventable if detected early.  Vaccination and regular screening can stop the disease before...
12/01/2026

Cervical cancer is largely preventable if detected early.
Vaccination and regular screening can stop the disease before it begins.





31/12/2025

As we reflect on a year defined by progress and purpose, Hetero extends its heartfelt appreciation to partners, caregivers, and communities who walked this journey with us.
As we step into 2026, we reaffirm our commitment to expanding access to affordable, life-saving medicines and advancing health for all.
Wishing you and your loved ones a year ahead filled with strength, hope, and good health.

Address

7-2-A2, Hetero Corporate Industrial Estates, Sanath Nagar
Hyderabad
500018

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm
Saturday 9am - 6pm

Telephone

+914023704923

Alerts

Be the first to know and let us send you an email when Hetero posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Hetero:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics. The company is globally recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products.

Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, approved by stringent global regulatory authorities. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc.

Hetero has a strong global presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide.